Elevance Health Inc. (ANTM)
Elevance Health Statistics
Share Statistics
Elevance Health has 237.46M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 237.46M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 237.04M |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 14.37 and the forward PE ratio is null. Elevance Health's PEG ratio is 6.15.
| PE Ratio | 14.37 |
| Forward PE | n/a |
| PS Ratio | 0.49 |
| Forward PS | null |
| PB Ratio | 2.08 |
| P/FCF Ratio | 18.87 |
| PEG Ratio | 6.15 |
Enterprise Valuation
Elevance Health has an Enterprise Value (EV) of 108.85B.
| EV / Sales | 0.62 |
| EV / EBITDA | 11.98 |
| EV / EBIT | 18.74 |
| EV / FCF | 23.91 |
Financial Position
The company has a current ratio of 2.01, with a Debt / Equity ratio of 0.76.
| Current Ratio | 2.01 |
| Quick Ratio | 2.01 |
| Debt / Equity | 0.76 |
| Debt / EBITDA | 3.44 |
| Debt / FCF | 6.86 |
| Interest Coverage | 6.67 |
Financial Efficiency
Return on Equity is 14.47% and Return on Invested Capital is 6.44%.
| Return on Equity | 14.47% |
| Return on Assets | 5.12% |
| Return on Invested Capital | 6.44% |
| Revenue Per Employee | $1.8M |
| Profits Per Employee | $60.9K |
| Employee Count | 98,200 |
| Asset Turnover | 1.51 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 1.93B |
| Effective Tax Rate | 24.46% |
Stock Price Statistics
The stock price has increased by 0% in the last 52 weeks. The beta is 0.97, so Elevance Health's price volatility has been higher than the market average.
| Beta | 0.97 |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 493.45 |
| 200-Day Moving Average | null |
| Relative Strength Index (RSI) | 51.21 |
| Average Volume (20 Days) | 1.18M |
Income Statement
In the last 12 months, Elevance Health had revenue of 176.81B and earned 5.98B in profits. Earnings per share was 26.29.
| Revenue | 176.81B |
| Gross Profit | 157.06B |
| Operating Income | 7.9B |
| Net Income | 5.98B |
| EBITDA | 9.09B |
| EBIT | 9.09B |
| Earnings Per Share (EPS) | 26.29 |
Balance Sheet
The company has 8.29B in cash and 31.23B in debt, giving a net cash position of -22.94B.
| Cash & Cash Equivalents | 8.29B |
| Total Debt | 31.23B |
| Net Cash | -22.94B |
| Retained Earnings | 33.55B |
| Total Assets | 100.82B |
| Working Capital | 29.28B |
Cash Flow
In the last 12 months, operating cash flow was 5.81B and capital expenditures -1.26B, giving a free cash flow of 4.55B.
| Operating Cash Flow | 5.81B |
| Capital Expenditures | -1.26B |
| Free Cash Flow | 4.55B |
| FCF Per Share | 19.55 |
Margins
Gross margin is 88.83%, with operating and profit margins of 4.47% and 3.38%.
| Gross Margin | 88.83% |
| Operating Margin | 4.47% |
| Pretax Margin | 4.47% |
| Profit Margin | 3.38% |
| EBITDA Margin | 5.14% |
| EBIT Margin | 4.47% |
| FCF Margin | 2.57% |
Dividends & Yields
ANTM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 6.96% |
| FCF Yield | 5.3% |
Analyst Forecast
Currently there are no analyst rating for ANTM.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Jun 1, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 1, 2005 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 3.57 |
| Piotroski F-Score | 8 |